Pharma companies reach out through CIIE
Pharma companies are leveraging the China International Import Expo to unveil new products and to announce important local tech partners who are vital in innovation.
Novartis and Tencent unveiled an artificial intelligence-powered heart failure disease management platform, combining AI, voice and image identification, and interactive experiences to help patients and their families to manage patient health, and keep doctors informed.
WeChat will provide self-service health evaluation, offer preliminary diagnosis of heart symptoms, and remind patients to take their medicine.
"This is just the first step of our collaboration with Tencent and we will explore more ways of using this model on other diseases," commented Ingrid Zhang, president of Novartis Pharma China.
Pfizer China is working with KingMed Diagnostics to raise awareness of issues concerning use of antibiotics and raise the diagnostic capability of community medical institutions.
Microsoft China will work to strengthen basic research through big data to improve the awareness of infectious diseases, and to assist in construction of a health information system.
Germany's Boehringer Ingelheim announced a competition to be held next year to help local startups.
“It’s time for Boehringer Ingelheim to join hands with Chinese partners to bolster innovation thanks to the unprecedented scientific innovations emerging in China, which is rapidly becoming an innovation hub for biomedical research worldwide," said Henri Doods, Global Head of Research Beyond Borders at Boehringer Ingelheim.
Winners will be selected during Boehringer Ingelheim Partnering Days on March 12 and 13 next year and be offered one-on-one guidance in addressing challenges and business growth.
According to a separate agreement, Boehringer Ingelheim is also working with online health care service platform such as JD's health division, Haodaifu Online, Pingan Healthcare and Technology Co to focus on chronic disease management, drug delivery, patient and health awareness education, and to offer one-stop online consultation and prescription and relevant services.
Fosun Pharma's MRIdian imaging solution by ViewRay is a one-of-its-kind radiotherapy solution that integrates MRI technology with radiation delivery providing higher precision and accuracy during surgery.
Chairman Chen Qiyu at Shanghai Fosun Pharmaceuticals said bringing in cutting-edge technologies is an essential step for the company's globalization blueprint.
It's also showcasing the latest version of the da Vinci surgical robot, which offers minimally invasive surgery. More than 100 such robots are already active in domestic hospitals.
Essilor Vision Foundation and the National Institute of Education Sciences' partnership will raise awareness of myopia. The French conglomerate in lens and eye-care hopes to cover more than 3,000 elementary schools and middle schools in the city through joint efforts with Shanghai Association for School Heath Care and Shanghai Research Center of Ophthalmology and Optometry.
Sanofi Pasteur, the vaccine arm of Sanofi has local industry partners in vaccination. It will work with Suzhou Shensu Automation Company to build intelligent vaccination clinics, streamline the overall vaccination processes, and better manage vaccine safety.
It hopes to forge closer ties with the Chinese Preventive Medicine Association and Ali Health for better access to immunization information and management of the vaccination process.